Jaime Rosenberg

Researchers identified 3 groups with distinctive patterns of overall survival (OS), among which they determined additional prognostic value in patients with <5% bone marrow blasts.

Just 24.7% of elderly patients with chronic obstructive pulmonary disease (COPD) included in the study demonstrated correct usage of their inhaler.

The study of over 8000 patients with myeloproliferative neoplasms (MPNs) also found that these patients were 40% more likely to have a prior diagnosis of inflammatory bowel disease (IBD).

The researchers found that just 13% of participating providers adhered to the recommended low dose (40 mg) of oral prednisone for patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).

Historically, there has been a lack of understanding around clinical and laboratory features and prognostic factors for children with myeloproliferative neoplasms (MPNs), as MPNs are especially rare in this patient population.

At the time of the 2-year analysis, 88% of the 17 infants who received the therapeutic dose of risdiplam for spinal muscular atrophy (SMA) were alive and did not require permanent ventilation.

By the age of 4 years, all children with type 1 SMA included in the study had subluxated hips.

Data from a meta-analysis suggest chronic obstructive pulmonary disease (COPD) could increase the risk of long-term all-cause mortality for patients with heart failure.

A year after the FDA approved Zolgensma for the treatment of spinal muscular atrophy in children aged under 2 years without end-stage weakness, researchers shared safety and early efficacy data from the first 21 children treated with the gene therapy in Ohio.

Based on assessments of ropeginterferon alpha-2b in a real-world setting, researchers highlighted the safety, tolerance, and efficacy of the treatment in Philadelphia-negative myeloproliferative neoplasm (MPNs).

Researchers found that 12% of patients underwent testing even after care teams determined they were actively dying of chronic obstructive pulmonary disease (COPD) and the aim of care shifted to comfort.

In a review of the polycythemia vera (PV) landscape, researchers outline new perspectives in the diagnosis, prognosis, and treatment of the disease.

Both neurofibromatosis type 1 (NF1) and Tuberous Sclerosis Complex (TSC) share similar types of manifestations; researchers hypothesized that the tool would be useful for NF1 in addition to TSC.

Researchers assess the psychosocial impact of allogeneic hematopoietic stem cell transplantation, particularly how preparing patients can assist in guiding health care providers in offering better care.

Implementing a multidisciplinary discussion has positive implications for both the diagnosis and management of interstitial lung disease (ILD), according to study findings.

The research spotlights the diverse landscape of pediatric cancer types harboring 2 types of genomic alterations.

The study confirms previous observations of different trajectories between the progression of the 2 spinal muscular atrophy subtypes, the researchers said.

Researchers provided an overview of what they deem a hopeful future for spinal muscular atrophy and Duchenne muscular dystrophy.

As rare disease registries to assess orphan drugs are mainly established by the pharmaceutical industry, researchers argued post-marketing registries, functioning as marketing tools, have an underestimated influence on clinical practice.

Results of a combined training program in 17 patients with multiple sclerosis indicate patients reap benefits from daily activities like walking or sitting-to-standing, and show the program reduces the dual-task cost of performing cognitive tasks while walking.

The authors suggest that recognizing the possible link may help identify patients at greater risk, although they do caution that larger studies are needed.

New findings indicate that relying on circulating tumor DNA (ctDNA) and tissue DNA tests are complementary measures that can better match patients with biliary tract cancer with precise therapies.

Remote patient monitoring of patients with COPD can offer clues about what happens before an exacerbation.

A review on the diagnosis, prevalence, and clinical impact of sarcopenia in chronic obstructive pulmonary disease (COPD) has found that sarcopenia is both prevalent and negatively impacts clinical outcomes in patients with the disease.

The results, indicating that ruxolitinib may be a promising option for children with steroid refractory advanced graft-versus-host disease (aGVHD), would need confirmation from a larger trial.

Patients were more likely to report more relapses of multiple sclerosis than physicians.

Counties with a smaller proportion of Latinos faced a Latino HIV prevalence rate that was nearly 4 times that of whites, according to a recent study.

A recent report illustrates how advances in allogeneic hematopoietic stem cell transplantation (HSCT) have impacted the outcomes of children with severe acute graft-versus-host-disease.

Can muscle mass predict whether patients with chronic obstructive pulmonary disease have a longer hospital stay?

A survey from Thailand noted that there is room for growth in HIV testing and identified the factors associated with testing.